XENE: Xenon Company Short-Term Debt
Xenon Pharmaceuticals (XENE) invests in selective ion inhibitors to combat epilepsy. Credit obligations under one year reflect borrowing dynamics, where the parameter mark equals 0.01. Risks are associated with potential test failures and capital shortages. The current strategy is based on completing the final stage of clinical trials before new drugs enter the market.
Financial and market metric breakdowns for Xenon Corp (XENE)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity details:
Debt to Equity Xenon Pharmaceuticals|XENE - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Xenon Pharmaceuticals|XENE - Company Cumulative Debt|Debt to Book Capitalization Ratio Xenon|XENE - Company Long-Term Indebtedness|Company Current Liabilities Xenon Pharmaceuticals|Quick Liquidity xenon-pharma.com
- earnings and valuation multiples indicators:
Basic company analysis:XENE - Xenon
Analyzing the short-term debt profile of Xenon Pharmaceuticals (XENE), an investor assesses the total liabilities with a maturity horizon of up to one year, which determines the current liquidity of the business. For this epilepsy therapy developer, an increase in this metric could signal the financing of expansion prior to the realization of multi-year patent-driven superprofits or the emergence of a working capital deficit.
Direct competitors
BIIB - Company Short-Term Debt|Company Short-Term Loans and Borrowings NBIX (Neurocrine)|Regencell (RGC) - Company Short-Term Debt|Short-Term Debt Axsome Corp (AXSM)|Company Current Liabilities ACAD|Company Short-Term Indebtedness VKTX (vikingtherapeutics.com)|Company Short-Term Debts SUPN|CPRX - Short-Term Debt|Company Short-Term Debt Denali Therapeutics Inc DNLI|HRMY: Company Short-Term Indebtedness|BHVN - Company Short-Term Debt|Short-Term Debt amylyx.com|Trevi Therapeutics, Inc. (TRVI) - Company Short-Term Debt|Company Short-Term Indebtedness PRAX|Company Current Liabilities AVXL|CBLL: Company Short-Term Loans and Borrowings|Company Short-Term Debt Prothena (PRTA)|ALEC: Current Liabilities|Company Short-Term Debts ANNX (Annexon)|Company Short-Term Loans and Borrowings OMER|Neurogene Corp - Company Short-Term Debts|ACIU - Company Short-Term Debts|Voyager Therapeutics (VYGR) - Company Short-Term Debt|neumoratx.com - Company Short-Term Loans and Borrowings|Company Short-Term Debt Scilex|Company Current Liabilities Tevogen Bio Holdings Inc. (TVGN)|Company Short-Term Debts ACOG|Company Short-Term Debts cogrx.com (CGTX)|Company Short-Term Debts IKT (Inhibikase Therapeutics)|SAVA - Company Current Liabilities|Assertio Therapeutics - Company Short-Term Debts|Short-Term Debt Coya Therapeutics, Inc.|VTGN (vistagen.com) - Company Current Liabilities|Ovid Therapeutics (OVID) - Company Short-Term Debts|Company Current Liabilities ABOS|CRVO (cervomed.com) - Amount of Current Liabilities|Company Short-Term Debts ATHE|Short-Term Debt Volume clene.com|Company Short-Term Debts PEPG (PepGen)|JUNS - Company Current Liabilities|Relmada Therapeutics - Company Short-Term Debts|ANVS - Company Short-Term Debts|gracetx.com (GRCE) - Company Short-Term Debt|AIFF (Firefly Neuroscience, Inc.) - Company Short-Term Debt|Company Short-Term Debt ANEW Medical|NeuroSense Therapeutics, Ltd. (NRSN) - Short-Term Debt Volume|Company Current Liabilities RVPH (Reviva Pharmaceuticals)|metaviatx.com - Company Short-Term Indebtedness|Company Short-Term Debts NRXS (NeurAxis)|Helius Medical Technologies, Inc. (HSDT) - Short-Term Debt|PASG - Company Short-Term Debt|NEUP (Neuphoria Therapeutics Inc.) - Company Short-Term Indebtedness|NERV: Company Short-Term Debts|Short-Term Debt athira.com (ATHA)|Company Short-Term Debt Addex Therapeutics Ltd|Company Short-Term Indebtedness ALZN (Alzamend)|Company Short-Term Debts CYCN|PTIX - Short-Term Debt|Pasithea Therapeutics Corp. - Company Current Liabilities|Company Short-Term Debts Cortigent Inc CRGT|ATXI - Company Short-Term Debt|Company Short-Term Loans and Borrowings BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Short-Term Debt|Short-Term Debt Chromocell (CHRO)|Company Current Liabilities ELYM|Company Short-Term Indebtedness ITCI (Intra-Cellular)|Company Short-Term Debts LBPH|MRNS - Short-Term Debt|Company Short-Term Debt NKGen NKGN|NRBO: Company Short-Term Indebtedness|SAGE - Company Short-Term Debt|Short-Term Debt synaptogen.com|Trevena (TRVN) - Company Short-Term Debt|Company Short-Term Indebtedness VIGL|Company Current Liabilities WENA|CERE: Company Short-Term Loans and Borrowings